Syncretic Clinical Research Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Syncretic Clinical Research Services
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepa Koluparambil and Amith Krishnan serve as directors at the Company.
- CIN/LLPIN
U74900KA2014PTC076150
- Company No.
076150
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Syncretic Clinical Research Services Private Limited offer?
Syncretic Clinical Research Services Private Limited offers a wide range of products and services, including Graduation & High Education Programs, Medical Educational Service.
Who are the key members and board of directors at Syncretic Clinical Research Services?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amith Krishnan  | Managing Director | 02-Sep-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepa Koluparambil | Director | 02-Sep-2014 | Current |
Financial Performance and Corporate Structure Insights of Syncretic Clinical Research Services.
Syncretic Clinical Research Services Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Syncretic Clinical Research Services?
In 2017, Syncretic Clinical Research Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Palmcube Corporation Private Limited
Active 7 years 6 monthsDeepa Koluparambil and Amith Krishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syncretic Clinical Research Services?
Unlock and access historical data on people associated with Syncretic Clinical Research Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syncretic Clinical Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncretic Clinical Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
